NCT01510379View on ClinicalTrials.gov

Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

August 31, 2012

Conditions
Nausea and Vomiting Post-foregut Surgery
Interventions
DEVICE

Reletex

Neurostimulation device for prevention/treatment of post-operative nausea and vomiting, Reletex arm.

DRUG

IV ondansetron 4 mg q 6 hours for a total of 4 doses

DRUG

IV promethazine 25 mg q 6 hours prn

DRUG

Elixir promethazine 25 mg q 6 hours prn after discharge

Trial Locations (1)

43210

The Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

Kyle A Perry

OTHER

NCT01510379 - Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut Surgery | Biotech Hunter | Biotech Hunter